Delivra Health Brands Inc

Delivra Health Brands Inc

0.06
EUR
0.00
(0.00%)
-0.04EPS
Oct 23Next Earn
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.01
0.06
0.33
0.36
0.35
0.32
0.39
0.43
0.32
Basic EPS, GAAP
-0.21
-0.21
-0.26
-0.2
-0.17
-1.57
-1.05
-1.55
-3.72
-1.26
-0.28
-0.01
0.03
-0.06
Free Cash Flow per Basic Share
-0.23
-0.21
-0.25
-0.15
-0.16
-1.35
-1.15
-1.74
-1.15
-0.43
-0.18
-0.04
0.03
-0.05
Dividend per Share
- -
- -
- -
- -
- -
0.37
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.58
0.37
0.29
0.09
-0.05
2.6
6.04
4.77
1.56
0.39
0.13
0.13
0.17
0.09
Tangible Book Value per Share
0.58
0.37
0.29
0.09
-0.05
2.59
4.11
2.94
0.97
0.16
-0.01
0.04
0.13
0.09
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
5
12
18
21
23
25
25
29
31
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
6
8
8
8
10
12
10
Operating Margin (%)
- -
- -
- -
- -
- -
-10,855.18
-1,251.93
-304.18
-201.64
-116.39
-73.87
-13.92
-5.74
-17.35
Depreciation Expense
- -
- -
- -
- -
- -
1
- -
1
3
3
2
1
1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-8
-13
-28
-80
-29
-7
- -
1
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-11,110.24
-1,736.5
-465.6
-1,026.18
-358.7
-86.12
-1.88
7.08
-19.56
Working Capital
- -
- -
- -
- -
- -
15
61
27
9
3
1
2
6
5
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
2
2
2
Total Equity
- -
- -
- -
- -
- -
23
105
93
37
10
3
3
5
3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-11.34
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
16.63
- -
Return on Common Equity (%)
-33.14
-44.73
-70.3
-104.47
- -
- -
-19.69
-28.79
-130.85
-131.23
-105
-5.44
20.41
-53.83

Capital Structure

CAD

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
31
31
31
Market Capitalization
- -
- -
- -

Working Capital

CAD

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
9
8
7
Cash, Cash Equivalents & STI
3
3
3
Accounts Receivable, Net
3
3
2
Inventories
2
2
2
Total Current Liabilities
3
2
2
Payables & Accruals
3
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-19,110.01%
-29.18%
53.26%
Free Cash Flow
1,998.45%
-75.46%
-166.96%
Net Income, GAAP
2,173.25%
-125.29%
-576.09%
Sales/Revenue/Turnover
- -
16.27%
26.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4
2
3
4
12
2025
2
1
3
3
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
-0.02
-0.01
0.05
0.03
2025
-0.01
-0.03
-0.01
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

CEO
Gord Davey
Full Time Employees
22
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
999 Canada Place Vancouver BC Canada V6C 3E2
IPO Date
Mar 31, 2017
Business
Delivra Health Brands Inc. operates globally, delivering health and wellness consumer products to individuals and patients across various regulated markets. The company’s portfolio encompasses sleep aids, as well as topical pain and anxiety relief solutions. Its offerings feature a range of products including liquid sleep formulas, ingestible gummies, and powdered sleep supplements under the Dream Water brand. For physical discomfort, the company provides creams designed for pain relief, including specialized infused topical options available in Canadian regulated channels. These products are brought to market under the LivRelief, Dream Water, and LivRelief Infused trademarks. Originally known as Harvest One Cannabis Inc., Delivra Health Brands Inc. maintains its primary corporate offices in Vancouver, Canada.

Company News

  • Delivra Health Brands launches LivRelief Itch Cream - ICYMI

  • Delivra Health Brands launches LivRelief Itch Cream - ICYMI

  • Delivra Health launches LivRelief Itch Relief Cream in Canada

  • Robinhood shares rise on launch of new blockchain network

  • Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market

  • Delivra Health launches LivRelief Itch Relief Cream in Canada

  • Delivra Health brands reports e-commerce growth – ICYMI

  • Delivra Health and Its Brands Dream Water(R) and LivRelief(TM) Report Results for Third Quarter of Fiscal 2026

  • Berkshire Hathaway reports higher Q1 operating earnings under new CEO Greg Abel

  • Delivra Health Brands expands LivRelief with Peak Processing Solutions partnership - ICYMI

  • Delivra Health Brands expands LivRelief with Peak Processing Solutions partnership - ICYMI

  • Intel stock pops on strong first quarter report, upbeat guidance

  • Tesla sees analyst support on strong auto margins, AI strategy after Q1 beat

  • Delivra Health Brands inks licensing deal with Peak Processing Solutions to expand LivRelief in Canada

  • Delivra Health Brands inks licensing deal with Peak Processing Solutions to expand LivRelief in Canada

  • Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)

  • Delivra Health targets kids sleep market growth – ICYMI

  • Lindian brings Kangankunde closer to production with Tipume camp milestone

  • Delivra Health to launch Kids Sleep Gummies in US in June

  • Super Micro Computer stock tumbles after co-founder charged in Nvidia GPU smuggling case